Eko Health Announces Large-Scale Deployment of AI Heart Disease Detection Technology

Imperial College London and UK NHS initiates TRICORDER program in primary care across the United Kingdom, targeting Heart Failure, Valvular Heart Disease, and Atrial Fibrillation EMERYVILLE, Calif. , Nov. 6, 2023 /PRNewswire/ — Eko Health, Inc. (Eko), a leader in AI technology for heart…

Click here to view original post